A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Multiple studies suggest that lipid oversupply to skeletal muscle contributes to the development of insulin resistance, perhaps by promoting the accumulation of lipid metabolites capable of inhibiting signal transduction. Herein we demonstrate that exposing muscle cells to particular saturated free fatty acids (FFAs), but not mono-unsaturated FFAs, inhibits insulin stimulation of Akt/protein kinase B, a serine/threonine kinase that is a central mediator of insulin-stimulated anabolic metabolism. These saturated FFAs concomitantly induced the accumulation of ceramide and diacylglycerol, two products of fatty acyl-CoA that have been shown to accumulate in insulin-resistant tissues and to inhibit early steps in insulin signaling. Preventing de novo ceramide synthesis negated the antagonistic effect of saturated FFAs toward Akt/protein kinase B. Moreover, inducing ceramide buildup recapitulated and augmented the inhibitory effect of saturated FFAs. By contrast, diacylglycerol proved dispensable for these FFA effects. Collectively these results identify ceramide as a necessary and sufficient intermediate linking saturated fats to the inhibition of insulin signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, an overabundance of SFA (e.g., Palmitate) can induce IR through the accumulation of lipid derivatives including DAGs, ceramides and long chain acyl-CoAs in the cytosol, which in turn can interfere with IRS1-PKB signalling [113,114,115,116,117,118].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [118]
Experimental — accuracy not yet measuredIn the citing paper
“The deleterious effect of ceramide on insulin signalling results from its ability to block the activation of AKT via two independent mechanisms (Chavez and Summers, 2012). The first mechanism involves the phosphorylation of AKT on pleckstrin homology domain by PKCζ, which in turn is activated by ceramide. This lowers the affinity of AKT for phosphoinositide (Powell et al., 2003) and blocks AKT”
From Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet (2019) · cites this paper as Chavez et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Itani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Boden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Self-citationPhosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953
Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM
Reaven, G. M., Hollenbeck, C., Jeng, C.-Y., Wu, M. S., & Chen, Y.-D. I. (1988) · Diabetes · doi:10.2337/diab.37.8.1020 · Cited by 753
Research works printed but not linked: 5
- Chen, 1991, Trans. Assoc. Am. Physicians, 104, 206
- Motley, 2001, Cell. Mol. Biol. (Noisy-le-Grand), 47, 1059
- Minamide, 2003, Methods Cell Biol.
- Yang, 1991, Mol. Cell. Biol., 11, 1988
- Chin, 1994, Mol. Endocrinol., 8, 51
Cited by
Items 401–500 of 627
Søgaard, D., Østergård, T., Błachnio-Zabielska, A. U., Baranowski, M., Vigelsø, A., Andersen, J. L., Dela, F., & Helge, J. W. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2372741 · Cited by 22
Qin, N., Bayat, A. R., Trevisi, E., Minuti, A., Kairenius, P. K., Viitala, S. M., Mutikainen, M., Leskinen, H. M., Elo, K., Kokkonen, T., et al. (2018) · Journal of Dairy Science · doi:10.3168/jds.2017-14298 · Cited by 21
Lin, J.-S., Dong, H., Chen, G., Chen, Z.-Y., Dong, X., Zheng, J., & Chen, Y. (2018) · Nutrients · doi:10.3390/nu10101393 · Cited by 23
Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview
Ross, J. S., Russo, S. B., Chavis, G. C., & Cowart, L. A. (2014) · Clinical Lipidology · doi:10.2217/clp.14.37 · Cited by 21
Mitochondria and endoplasmic reticulum: Targets for a better insulin sensitivity in skeletal muscle?
Boulinguiez, A., Staels, B., Duez, H., & Lancel, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.05.011 · Cited by 28
Yang, C., Lim, W., Bazer, F. W., & Song, G. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.11.005 · Cited by 20
“SFA is a highly selective inducer of sphingolipids, such as ceramide, and induced ceramide by SFA exposure inhibits AKT activation in various nonadipose cells [28,29].”
BackgroundBlackburn, M. L., Ono‐Moore, K. D., Sobhi, H. F., & Adams, S. H. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00515.2019 · Cited by 23
How Ceramides Orchestrate Cardiometabolic Health—An Ode to Physically Active Living
Carrard, J., Gallart‐Ayala, H., Weber, N., Colledge, F., Streese, L., Hanssen, H., Schmied, C. M., Ivanišević, J., & Schmidt‐Trucksäss, A. (2021) · Metabolites · doi:10.3390/metabo11100675 · Cited by 23
“In fact, an accumulation of ceramides in muscle cells and adipocytes also inhibits Akt/PKB, reduces GLUT4 translocation to the membrane, and ultimately decreases glucose uptake [43,47,48].”
BackgroundCeramides inhibit phospholipase D-dependent insulin signaling in liver cells of old rats
Babenko, N. A., & Kharchenko, V. S. (2012) · Biochemistry (Moscow) · doi:10.1134/s0006297912020095 · Cited by 20
Verma, M. K., Yateesh, A. N., Neelima, K., Pawar, N., Sandhya, K., Poornima, J., Lakshmi, M. N., Yogeshwari, S., Pallavi, P. M., Oommen, A. M., et al. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-255 · Cited by 24
“Moreover, conversion of ceramide to sphingosine by ceramidase hence providing substrate for S1P generation exerts negative correlation with FFA induced insulin resistance (Chavez et al. 2003, 2005).”
Ceramide and Insulin Resistance: How Should the Issue Be Approached?
Górski, J. (2012) · Diabetes · doi:10.2337/db12-1157 · Cited by 19
“On the contrary, inhibition of the enzyme markedly augmented both basal- and palmitate-induced level of ceramide in C2C12 cells (12).”
BackgroundAn adipocentric perspective of pancreatic lipotoxicity in diabetes pathogenesis
Risi, R., Vidal‐Puig, A., & Bidault, G. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0313 · Cited by 19
Parra, P., Serra, F. A., & Palou, A. (2012) · Genes & Nutrition · doi:10.1007/s12263-011-0279-x · Cited by 18
“Ceramide accumulation is considered a potential mediator of insulin resistance and lipotoxicity (Chavez et al. 2003; Summers 2006).”
BackgroundAlipourfard, I., Bakhtiyari, S., Gheysarzadeh, A., Renzo, L. D., LORENZO, A. D., Mikeladze, D., & Khamoushi, A. (2020) · Current Molecular Medicine · doi:10.2174/1566524020666200427102209 · Cited by 18
Bioactive Sphingolipids as Major Regulators of Coronary Artery Disease
Song, J.-H., Kim, G., Park, K., Park, W., & Park, T. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2020.218 · Cited by 18
“This explains 376https://doi.org/10.4062/biomolther.2020.218 the mechanism by which only saturated fats (and not the unsaturated ones) drive the synthesis of sphingolipids (Chavez et al., 2003; Holland et al., 2007).”
BackgroundInfluentialLi, A., Pengcheng, S. H. E. N., Liu, S., Wang, J., Jingru, Z. E. N. G., & Du, C. (2021) · Food Science and Technology · doi:10.1590/fst.47921 · Cited by 18
Tous les acides gras saturés ont-ils le même effet métabolique ?
Walrand, S., Fisch, F., & Bourre, J. M. (2010) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2010.02.003 · Cited by 29
Li, X., Jin, S., Su, J., Li, X., & Xu, M. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13073 · Cited by 18
Ardah, M. T., Parween, S., Varghese, D. S., Emerald, B. S., & Ansari, S. A. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.09.006 · Cited by 18
Nisr, R. B., Shah, D. S., & Hundal, H. S. (2020) · Cellular Physiology and Biochemistry · doi:10.33594/000000282 · Cited by 20
Smith, I. J., Huffman, K. M., Durheim, M. T., Duscha, B. D., & Kraus, W. E. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90216.2008 · Cited by 19
“SPT, which participates in de novo ceramide synthesis (5), also appears to play an important role in muscle ceramide metabolism and insulin resistance.”
A Lupinoside prevented fatty acid induced inhibition of insulin sensitivity in 3T3 L1 adipocytes
Dey, D., Pal, B. C., Biswas, T., Roy, S. S., Bandyopadhyay, A., Mandal, S. K., Giri, B. B., & Bhattacharya, S. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9378-1 · Cited by 17
Mihai, A. D., & Schröder, M. (2014) · Adipocyte · doi:10.4161/21623945.2014.989728 · Cited by 19
“4A), which is consistent with several other reports.49–56 To validate that our BSA-palmitate complexes induce ER stress, we characterized XBP1 splicing in undifferentiated preadipocytes exposed to palmitate complexed to BSA.”
InfluentialNaderali, E. K., Fatani, Abubakari, Itua, I., Wong, C., & Thomas (2012) · International Journal of General Medicine · doi:10.2147/ijgm.s31819 · Cited by 20
“10,11 There is a close relationship between insulin resistance and visceral adiposity.”
Pdcd2l Promotes Palmitate-Induced Pancreatic Beta-Cell Apoptosis as a FoxO1 Target Gene
Yin, Y., Wei, Y. Q., Yu, J., Zhang, X., Lin, H., Zhu, Y., & Han, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166692 · Cited by 16
Choi, H., Kim, Y.-S., Lee, H.-J., & Cheon, H. G. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174011 · Cited by 16
Babenko, N. A., & Kharchenko, V. S. (2015) · Biochemistry (Moscow) · doi:10.1134/s0006297915010125 · Cited by 16
Pesce, V., Maccagnano, G., Vicenti, G., Notarnicola, A., Moretti, L., Tafuri, S., Vanni, D., Salini, V., & Moretti, B. (2014) · PubMed · Cited by 20
The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity
Cusi, K. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_1 · Cited by 19
Mai, K., Andres, J., Bobbert, T., Aßmann, A., Biedasek, K., Diederich, S., Graham, I. A., Larson, T. R., Pfeiffer, A. F. H., & Spranger, J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.018 · Cited by 16
“[9] Chavez JA, Knotts TA, Wang LP, et al.”
BackgroundBłachnio-Zabielska, A. U., Roszczyc-Owsiejczuk, K., Imierska, M., Pogodzińska, K., Rogalski, P., Daniluk, J., & Zabielski, P. (2022) · Cells · doi:10.3390/cells11020206 · Cited by 18
Moreira, R., Martins, A. D., Ferreira, R. M., Alves, M. G., Pereira, M. D. L., & Oliveira, P. F. (2023) · Antioxidants · doi:10.3390/antiox13010040 · Cited by 16
“Moreover, it has been shown that PA inhibits the insulin cascade by being converted to ceramide, which breaks the pathway by hindering Akt action, which follows IRS-1 in the insulin signaling cascade [54,55].”
Gorgani‐Firuzjaee, S., Ahmadi, S., & Meshkani, R. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.006 · Cited by 16
Kasbi-Chadli, F., Coué, M., Aguesse, A., Grit, I., Souque, T., Ferchaud‐Roucher, V., & Ouguerram, K. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02589-x · Cited by 15
“On the other hand, the inhibition of ceramide synthesis by myriocin was described to restore the insulin sensitivity in lipid-induced insulin-resistant cell culture [44, 47].”
BackgroundSingleton, J. R., Foster-Palmer, S. C., & Marcus, R. L. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210923125832 · Cited by 15
Ceramide dependent lipotoxicity in metabolic diseases
Li, Y., Tippetts, T. S., & Chaurasia, B. (2017) · Nutrition and Healthy Aging · doi:10.3233/nha-170032 · Cited by 16
“Despite this contention, the initial in vitro studies convincingly demonstrated that increasing ceramide content in skeletal muscle cells potently inhibits insulin signaling [42, 83, 84].”
BackgroundInfluentialCervone, D. T., Hucik, B., Lovell, A. J., & Dyck, D. J. (2020) · Metabolism Open · doi:10.1016/j.metop.2020.100026 · Cited by 14
Fillmore, N., Keung, W., Kelly, S. E., Proctor, S. D., Lopaschuk, G. D., & Ussher, J. R. (2015) · Experimental Physiology · doi:10.1113/ep085052 · Cited by 15
“2003), whereas ceramide-induced PP2A activation dephosphorylates Akt at serine 473, which is essential for Akt activity (Chavez et al. 2003).”
BackgroundJung, H. L., & Kang, H. Y. (2010) · Korean Diabetes Journal · doi:10.4093/kdj.2010.34.4.244 · Cited by 13
“We observed that muscular lipid accumulation and diverse lipids caused by a high fat diet interrupted insulin signal transduction and GLUT-4 translocation [9,37], especially muscular lipid accumulation suppressed sphingomyelinase activity and increased muscular sphingomyelin concentration, and ceramide accumulation ca…”
BackgroundInterplay between ceramides and phytonutrients: New insights in metabolic syndrome
Shabbir, M. A., Mehak, F., Khan, Z. M., Ahmad, W., Khan, M. R., Zia, S., Rahaman, A., & Aadil, R. M. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.03.010 · Cited by 16
Wang, P., Li, C. G., Zhou, X., & Ding, S. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13600 · Cited by 13
Stefanyk, L. E., Gulli, R. A., Ritchie, I. R. W., Chabowski, A., Snook, L. A., Bonen, A., & Dyck, D. J. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00636.2010 · Cited by 18
“The differences seen with the Ser473 phosphorylation of Akt mimicked that of Thr308 represented above. a,bDifferent letters denote significance (P 0.05).”
BackgroundInfluentialtBHQ Induces a Hormetic Response That Protects L6 Myoblasts against the Toxic Effect of Palmitate
Posadas-Rodríguez, P., Posadas-Rodríguez, N. E., González‐Puertos, V. Y., Toledo-Pérez, R., Ventura-Gallegos, J. L., Zentella‐Dehesa, A., Gómez-Quiroz, L. E., Königsberg, M., & Luna‐López, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3123268 · Cited by 15
“Since palmitate conjugation to bovine serum albumin (BSA) creates an aqueoussoluble reagent that can be absorbed and utilized by cells, it has been usually used as a transporter and stabilizing agent for fatty acids for that kind of experiments [39].”
BackgroundLong-chain Acyl-CoA is not primarily increased in myotubes established from type 2 diabetic subjects
Just, M., Færgeman, N. J., Knudsen, J., Beck‐Nielsen, H., & Gaster, M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.005 · Cited by 16
Polyunsaturated fatty acids prevent myosteatosis and lipotoxicity
Brun, A., Denis, P., Rambeau, M., Rigaudière, J., Jouve, C., Mazurak, V. C., & Capel, F. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109722 · Cited by 14
Sabin, M. A., Yau, S. W., Russo, V. C., Clarke, I. J., Dunshea, F. R., Chau, J., Cox, M., & Werther, G. A. (2011) · Obesity · doi:10.1038/oby.2011.55 · Cited by 12
“This was preferred to development of in-house primary porcine muscle cultures, as the C2C12 cell line has been more intensively characterized and specific changes in response to fatty acid dosing have been previously published (26).”
MethodBioactive lipids and metabolic syndrome—a symposium report
DeVito, L. M., Dennis, E. A., Kahn, B. B., Shulman, G. I., Witztum, J. L., Sadhu, S., Nickels, J. T., Spite, M. R., Smyth, S. S., & Spiegel, S. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14752 · Cited by 13
Influence of the Human Lipidome on Epicardial Fat Volume in Mexican American Individuals
Leandro, A. C., Michael, L. F., Almeida, M., Kuokkanen, M., Huynh, K., Giles, C., Duong, T., Diego, V. P., Duggirala, R., Clarke, G. D., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.889985 · Cited by 15
“Hepatocellular ceramides stimulate fatty acid uptake (85) and decrease glucose uptake (85, 86), which enables hepatocytes to favor fatty acids over glucose as a preferred energy source and leads to NAFLD (85).”
BackgroundLiao, R., Babatunde, A. S., Qiu, S., Harikumar, H., Coon, J. J., Overmyer, K. A., Hannun, Y. A., Luberto, C., & Bresnick, E. H. (2023) · Nature Communications · doi:10.1038/s41467-023-42978-w · Cited by 12
Imierska, M., Zabielski, P., Roszczyc-Owsiejczuk, K., Sokołowska, E., Pogodzińska, K., Kojta, I., & Błachnio-Zabielska, A. U. (2022) · Cells · doi:10.3390/cells11071123 · Cited by 13
Accumulation of intramuscular toxic lipids, a link between fat mass accumulation and sarcopenia
Capel, F., Pinel, A., & Walrand, S. (2019) · OCL · doi:10.1051/ocl/2019023 · Cited by 12
Ruiz, M., Henricsson, M., Borén, J., & Pilon, M. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01600-y · Cited by 12
Therapeutic remodeling of the ceramide backbone prevents kidney injury
Nicholson, R. J., Cedeño-Rosario, L., Maschek, J. A., Lonergan, T., Vranken, J. G. V., Kruse, A. R. S., Stubben, C., Wang, L., Stuart, D., Alcantara, Q. A., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.006 · Cited by 13
Self-citationYou aren't IMMUNE to the ceramides that accumulate in cardiometabolic disease
Varre, J. V., Holland, W. L., & Summers, S. A. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159125 · Cited by 13
Self-citationTargeting Ceramides and Adiponectin Receptors in the Islet of Langerhans for Treating Diabetes
Li, W. (2022) · Molecules · doi:10.3390/molecules27186117 · Cited by 11
Wohlers, L. M., Powers, B. L., Chin, E. R., & Spangenburg, E. E. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00617.2012 · Cited by 12
Newsom, S. A., Everett, A. C., Park, S., Pelt, D. W. V., Hinko, A., & Horowitz, J. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120871 · Cited by 12
“palmitate (C16:0)), which potently impairs insulin signaling [2–4].”
BackgroundPollak, N., Janežič, E. G., Šink, Ž., & Ugwoke, C. K. (2025) · Metabolites · doi:10.3390/metabo15090581 · Cited by 13
“…ceramides either activate protein phosphatase 2A (PP2A), which dephosphorylates AKT at Thr308/Ser473, or induce atypical protein kinase C (aPKC λ / ζ ) activity, which interferes with AKT’s membrane translocation and binding to phosphatidylinositol (3,4,5)-trisphosphate (PIP3) [235,236].”
The beneficial impact of curcumin on cardiac lipotoxicity
Abolfazli, S., Butler, A. E., Kesharwani, P., & Sahebkar, A. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae102 · Cited by 13
Weyrich, P., Kapp, K., Niederfellner, G. J., Melzer, M., Lehmann, R., Häring, H., & Lammers, R. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0253 · Cited by 12
Ferchaud‐Roucher, V., Zaïr, Y., Aguesse, A., Krempf, M., & Ouguerram, K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa459 · Cited by 13
Škop, V., Malínská, H., Trnovská, J., Hüttl, M., Cahová, M., Błachnio-Zabielska, A. U., Baranowski, M., Burian, M., Oliyarnyk, O., & Kazdová, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122768 · Cited by 11
“They are also associated with inflammation, oxidative stress, mitochondrial dysfunction and other metabolic disturbances [63,64].”
BackgroundRegulation of Free Fatty Acid by Sitagliptin Monotherapy in DRUG-NAÏVE Subjects with Type 2 Diabetes
Kutoh, E., Wada, A., & Hayashi, J. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0287 · Cited by 10
Neurotensin negatively modulates Akt activity in neurotensin receptor‐1‐transfected AV12 cells
Liu, F., Yang, P., Baez, M., & Ni, B. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20098 · Cited by 10
“Studies with overexpression of constitutively active or dominant negative forms of Akt/PKB as well as with anti-Akt/PKB antibodies indicate the involvement of Akt in the regulation of anabolic metabolism [Chavez et al., 2003].”
BackgroundRigamonti, A. E., Dei, M., Caroli, D., Col, A. D., Cella, S. G., Paroni, R. C., & Sartório, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087451 · Cited by 11
“This is supposed to be due to the blockade of insulin-stimulated AKT, a key serine/threonine kinase that regulates gluconeogenesis in the liver and glucose uptake in adipose and muscle tissue [11,50].”
BackgroundRole of ceramides in diabetic foot ulcers (Review)
Wang, Y., Sun, Z., Zang, G., Zhang, L., & Wang, Z. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5229 · Cited by 12
Molecular Mechanisms Involved in Insulin Resistance: Recent Updates and Future Challenges
Singh, A., Ghai, N., & Bedi, P. M. S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104806 · Cited by 9
Tranilast protects pancreatic β-cells from palmitic acid-induced lipotoxicity via FoxO-1 inhibition
Choi, H., Kim, D. Y., Choi, M. J., Kim, J. I., Kim, O., Lee, J. W., Seo, E., & Cheon, H. G. (2023) · Scientific Reports · doi:10.1038/s41598-022-25428-3 · Cited by 10
Fiber Specific Changes in Sphingolipid Metabolism in Skeletal Muscles of Hyperthyroid Rats
Chabowski, A., Żendzian‐Piotrowska, M., Mikłosz, A., Łukaszuk, B., Kurek, K., & Górski, J. (2013) · Lipids · doi:10.1007/s11745-013-3769-3 · Cited by 9
“palmitate, a major representative of serum FFA) [34] and some studies show that de novo ceramide synthesis can be driven exclusively by increased availability of fatty acids [35, 36].”
BackgroundNevalainen, M. T. (2012) · Cited by 8
Shanmugam, Y., chokkalingam, D., Gopinath, G. R., Moses, A. C., Thanikachalam, P., Sathyanarayanan, P. M., & Bharathy, P. (2025) · Sustainable Chemistry for Climate Action · doi:10.1016/j.scca.2025.100089 · Cited by 14
The relation of leptin and insulin with obesity-related cardiovascular risk factors in US adults
Reis, J. P., Macera, C. A., Wingard, D. L., Araneta, M. R. G., Lindsay, S. P., & Marshall, S. J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.015 · Cited by 9
Podocytopathy in Obesity: Challenges of Living Large
Giannini, G., Kopp, J. B., & Rosenberg, A. Z. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.06.003 · Cited by 11
Verma, M. K., Yateesh, A. N., Smitha, R., Neelima, K., Pallavi, P. M., Reddy, M., Poornima, J., Oommen, A. M., Jagannath, M. R., & Somesh, B. P. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-251 · Cited by 9
“Palmitate treatment can also increase inflammatory cytokines gene expression and downstream signaling, oxidative stress and ceramide synthesis (Schmitz-Peiffer et al. 1999; Chavez et al. 2003; Jové et al. 2006; Rachek et al. 2007; Yuzefovych et al. 2010).”
Qin, N., Kokkonen, T., Salin, S., Seppänen‐Laakso, T., Taponen, J., Vanhatalo, A., & Elo, K. (2017) · Metabolomics · doi:10.1007/s11306-016-1160-0 · Cited by 8
“Further, in vitro and in vivo studies on the molecular level have demonstrated that Cers prevented the translocation of protein kinase B (Akt/PKB) in phosphoinositide 3 kinase (PI3-K) of the insulin signaling pathway through the activation of either protein kinase C (PKC) or protein phosphatase 2A (PP2A) in the muscle…”
Łukaszuk, B., Mikłosz, A., Żendzian‐Piotrowska, M., Wójcik, B., Górski, J., & Chabowski, A. (2017) · Journal of Diabetes Research · doi:10.1155/2017/3437169 · Cited by 8
Parameswara, V., Sule, A. J., & Esser, V. (2005) · PubMed · Cited by 7
Bellenger, J., Bellenger, S., Bourragat, A., Escoula, Q., Weill, P., & Narce, M. (2021) · OCL · doi:10.1051/ocl/2021006 · Cited by 7
Fedoryszak-Kuśka, N., Panasiewicz, M., Domek, H., & Pacuszka, T. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2014_930 · Cited by 7
Sun, X., Song, M., Wang, H., Zhou, H., Wang, F., Li, Y., Zhang, Y., Zhang, W., Zhong, M., & Ti, Y. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.154 · Cited by 7
Wu, H., Dridi, S., Huang, Y., & Baum, J. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00241.2019 · Cited by 7
Contribution Of Sphingolipids To The Pathogenesis Of Obesity
Samad, F. (2007) · Future Lipidology · doi:10.2217/17460875.2.6.625 · Cited by 8
The role of sphingolipids in heart failure
Hamouche, R., Summers, S. A., Holland, W. L., Navankasattusas, S., Drakos, S. G., & Tseliou, E. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf035 · Cited by 7
“10 Cer have been linked to metabolic and neurodegenerative diseases such as obesity, diabetes mellitus, 11–13 Alzheimer’s disease, 14,15 and Parkinson’s disease.”
Self-citationPuig, N., Rives, J., Gil, P., Miñambres, I., Ginel, A., Taurón, M., Bonaterra‐Pastra, A., Hernández‐Guillamón, M., Pérez, A., Sánchez‐Quesada, J. L., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116779 · Cited by 8
Ceramide microdomains: the major influencers of the sphingolipid media platform
Weber-Stout, M., Nicholson, R. J., Dumaguit, C. D. C., Holland, W. L., & Summers, S. A. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231395 · Cited by 6
Self-citationLipidomic Profiling at the Interface of Metabolic Surgery and Cardiovascular Disease
Ban, R. H., Kamvissi, V., Schulte, K., Bornstein, S. R., Rubino, F., & Graessler, J. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0455-8 · Cited by 8
Gilloteaux, J., Nicaise, C., Sprimont, L., Bissler, J. J., Finkelstein, J. A., & Payne, W. R. (2021) · Ultrastructural Pathology · doi:10.1080/01913123.2021.1983099 · Cited by 7
Jieu, B., Sykorova, E. B., Rohleder, C., Marcolini, E., Hoffmann, A., Koethe, D., Leweke, F. M., & Couttas, T. A. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116005 · Cited by 6
“Notably, CBD-mediated effects towards oleolyethanolamide (OEA), a known inhibitor of ceramidase that prevents ceramide degradation, could also account for an accumulation of sphingolipids (77).”
BackgroundEndogenous Metabolites in Metabolic Diseases: Pathophysiologic Roles and Therapeutic Implications
Xiao, M., Zhou, N., Tian, Z., & Sun, C. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.04.017 · Cited by 6
Molecular mechanisms of insulin signaling
Iliya, I., Mohammed, B., Akuyam, S., Nok, A., Bauchi, Z. M., Tanko, M., Timbuak, J., & Yusuf, B. (2016) · Sub-Saharan African Journal of Medicine · doi:10.4103/2384-5147.176267 · Cited by 6
Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway
Kołakowski, A., Kurzyna, P. F., Żywno, H., Bzdęga, W., Harasim‐Symbor, E., Chabowski, A., & Konstantynowicz-Nowicka, K. (2021) · Molecules · doi:10.3390/molecules26113377 · Cited by 6
“As a result, there is decreased insulin sensitivity and decreased transport of glucose into the cell [14,15].”
BackgroundAssociations between Serum Saturated Fatty Acids Content and Mortality in Dialysis Patients
Sikorska-Wiśniewska, M., Mika, A., Śledziński, T., & Chmielewski, M. S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175051 · Cited by 6
“Moreover, SFA and their derivatives, ceramides, have been shown to induce insulin resistance [28,29].”
BackgroundHassouneh, L. K., Timofiychuk, O. A., & Babenko, N. A. (2018) · General Physiology and Biophysics · doi:10.4149/gpb_2017020 · Cited by 7
“At the same time, inhibition of the PP2A by okadaic acid prevents the ceramide-induced disruption of insulin signaling pathway in the C2C12 myotubes (Chavez et al. 2003), PC12 neurons (Salinas et al. 2000), adipocytes (Teruel et al. 2001) and human glioblastoma cell line (Zinda et al. 2001).”
BackgroundGT-11 impairs insulin signaling through modulation of sphingolipid metabolism in C2C12 myotubes
Rustamov, J., Roh, Y., Hong, J. T., & Yoo, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122534 · Cited by 6
P38α MAPK Coordinates Mitochondrial Adaptation to Caloric Surplus in Skeletal Muscle
Waingerten-Kedem, L., Aviram, S., Blau, A., Hayek, T., & Bengal, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147789 · Cited by 5
“Extensive research spanning decades has illuminated the connection between the intramuscular buildup of fat-derived metabolites and the progressive decline in skeletal muscle metabolism, which ultimately culminates in insulin resistance [2–4].”
BackgroundMechanism of Lipid Induced Insulin Resistance: An Overview
Bhattacharya, S., Kundu, R., Dasgupta, S., & Bhattacharya, S. (2012) · Endocrinology and Metabolism · doi:10.3803/enm.2012.27.1.12 · Cited by 7
“Many workers show palmitate as the most potent FA in inhibiting insulin activity [3,21,30,31] and the question confronting us is how palmitate imposes such defects.”
BackgroundMechanisms for Obesity Related Kidney Disease
Murlidharan, P., Kamaladevan, S., Balan, S., & Kartha, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-35358-2_12 · Cited by 5
The insulin centennial—100 years of milestones in biochemistry
Attie, A., Tang, Q.-Q., & Bornfeldt, K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101278 · Cited by 6
“Insulin receptor–induced activation of Akt explains many of the metabolic effects of insulin.”
BackgroundInfluentialInhibition of palmitic acid induced adipogenesis by natural polyphenols in 3T3-L1 adipocytes
John, C. M., & Arockiasamy, S. (2022) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-022-00689-4 · Cited by 6
“Working solution of PA (1:100) was made by dissolving in 2% (w/v) bovine serum albumin-DMEM (Chavez et al. 2003).”
MethodBarquissau, V., & Morio, B. (2011) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2011.07.003 · Cited by 10
Metadata
- Authors
- Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A.
- Affiliations
- Colorado State University (US)
- University of Kansas (US)
- Corresponding author
- Summers, Scott A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 12
- Pages
- 10297-10303
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1984413737
- Cited by
- 617
- References
- 67
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 19 · 2023: 15 · 2022: 18 · 2021: 36 · 2020: 30 · 2019: 25 · 2018: 27 · 2017: 38 · 2016: 32 · 2015: 31 · 2014: 29 · 2013: 33 · 2012: 44
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6424 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- March of Dimes Foundation
- American Heart Association
- Colorado State University
- National Institutes of Health (5r21dk059749-02, 5r21dk060676-02)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK59749, R21-DK60676, R01DK058784)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- ceramide, diacylglycerol, saturated fatty acids, insulin resistance, insulin signaling, Akt/protein kinase B, skeletal muscle, de novo ceramide synthesis, monounsaturated fatty acids
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Animals, Cells, Cultured, Ceramides, Diglycerides, Fatty Acids, Fatty Acids, Nonesterified, Insulin, Phosphorylation, Proto-Oncogene Proteins, Signal Transduction, Protein Serine-Threonine Kinases, Muscle, Skeletal, Glycogen Synthase Kinase 3, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.